Govindappa Nagaraj,Sastry Kedarnath,Soares Maria Melina
申请号：
US201715444527
公开号：
US10144934(B2)
申请日:
2017.02.28
申请国别(地区):
美国
年份:
2018
代理人:
Fuierer Marianne`Moore & Van Allen, PLLC
摘要：
The present invention relates generally to the field of generating fusion proteins to be used in cancer therapy, and more specifically, to nucleotide sequences encoding the fusion proteins, wherein the chimeric fusion proteins comprises at least one targeting moiety and at least one immunomodulatory moiety that counteracts the immune tolerance of cancer cells.
